Browsing Tag

BLENREP

SpringWorks Announces Expansion of Global, Non-Exclusive Collaboration with GSK for…

Eli Pacheco Sep 7, 2022 0

- SpringWorks to Receive $75 Million Equity Investment with Potential for an Additional $550 Million in Milestone Payments - - SpringWorks to Supply Nirogacestat for GSK’s Global Blenrep…

Health

SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and…

Eli Pacheco Oct 27, 2021 0

-- Based on Encouraging Preliminary Data Observed with the First Dose Exploration Cohort (0.95 mg/kg BLENREP Q3W + Nirogacestat) a Randomized Phase 2 Cohort Expansion to Compare Against 2.5…